ES8704917A1 - Procedimiento para prepararar derivados de 1-piperazinacarboximida. - Google Patents

Procedimiento para prepararar derivados de 1-piperazinacarboximida.

Info

Publication number
ES8704917A1
ES8704917A1 ES552001A ES552001A ES8704917A1 ES 8704917 A1 ES8704917 A1 ES 8704917A1 ES 552001 A ES552001 A ES 552001A ES 552001 A ES552001 A ES 552001A ES 8704917 A1 ES8704917 A1 ES 8704917A1
Authority
ES
Spain
Prior art keywords
compound
formula
preparation
pharmaceutical compositions
carboxamide derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES552001A
Other languages
English (en)
Other versions
ES552001A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia Animal Health Inc
Original Assignee
Ferrosan AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrosan AB filed Critical Ferrosan AB
Publication of ES552001A0 publication Critical patent/ES552001A0/es
Publication of ES8704917A1 publication Critical patent/ES8704917A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/21—Radicals derived from sulfur analogues of carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28—Radicals substituted by nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR DERIVADOS DE 1-PIPERAZINACARBOXAMIDA. CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA (II) CON UN COMPUESTO DE FORMULA (III), EN PRESENCIA DE ETANOL O BENCENO, ENTRE 0 Y 250JC Y DURANTE 0,5 A 72 HORAS, PARA OBTENER UN COMPUESTO DE FORMULA (I) Y SUS SALES DE ADICION DE ACIDO FARMACEUTICAMENTE ACEPTABLES, SIENDO: R1, H, HAL O TRIFLUOROMETILO; R2 Y R3 SE ELIGEN ENTRE H Y ALQUILO INFERIOR; R4 Y R5, H, ALQUENILO Y OTROS; W, HAL O ALQUIL O ARIL-SULFONATO; X, FCO, FCHOH Y OTROS; Y, -NR4R5 Y Z, O O S. SE UTILIZAN COMO AGENTES NEUROFARMACOLOGICOS.
ES552001A 1983-08-10 1986-02-14 Procedimiento para prepararar derivados de 1-piperazinacarboximida. Expired ES8704917A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8304361A SE8304361D0 (sv) 1983-08-10 1983-08-10 Novel 1-acylpiperazine derivatives novel 1-acylpiperazine derivatives

Publications (2)

Publication Number Publication Date
ES552001A0 ES552001A0 (es) 1987-04-16
ES8704917A1 true ES8704917A1 (es) 1987-04-16

Family

ID=20352166

Family Applications (3)

Application Number Title Priority Date Filing Date
ES535027A Expired ES8705411A1 (es) 1983-08-10 1984-08-09 Procedimiento para preparar derivados de 1-piperazinacarboxamida
ES552001A Expired ES8704917A1 (es) 1983-08-10 1986-02-14 Procedimiento para prepararar derivados de 1-piperazinacarboximida.
ES556989A Expired ES8802039A1 (es) 1983-08-10 1986-08-01 Procedimiento par preparar derivados de 1-piperazinacarboxamida

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES535027A Expired ES8705411A1 (es) 1983-08-10 1984-08-09 Procedimiento para preparar derivados de 1-piperazinacarboxamida

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES556989A Expired ES8802039A1 (es) 1983-08-10 1986-08-01 Procedimiento par preparar derivados de 1-piperazinacarboxamida

Country Status (16)

Country Link
US (1) US4935419A (es)
EP (1) EP0136274B1 (es)
JP (1) JPH0723364B2 (es)
AT (1) ATE47850T1 (es)
AU (1) AU569537B2 (es)
CA (1) CA1253148A (es)
DE (1) DE3480395D1 (es)
DK (1) DK157864C (es)
ES (3) ES8705411A1 (es)
FI (1) FI80449C (es)
HU (1) HU196977B (es)
IE (1) IE58065B1 (es)
IL (1) IL72563A (es)
NZ (1) NZ209166A (es)
SE (1) SE8304361D0 (es)
WO (1) WO1985000811A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8500573D0 (sv) * 1985-02-08 1985-02-08 Ferrosan Ab Novel piperazinecarboxamides having a phenoxyalkyl or thiophenoxyalkyl side chain
GB8713240D0 (en) * 1987-06-05 1987-07-08 Proteus Biotech Ltd Hormones
CA1326451C (en) * 1988-01-26 1994-01-25 Nippon Chemiphar Co., Ltd. Therapeutic agent for liver disease and piperazine derivatives
US5795894A (en) * 1995-05-02 1998-08-18 Schering Corporation Piperazino derivatives as neurokinn antagonists
US5719156A (en) * 1995-05-02 1998-02-17 Schering Corporation Piperazino derivatives as neurokinin antagonists
US5892039A (en) * 1995-08-31 1999-04-06 Schering Corporation Piperazino derivatives as neurokinin antagonists
US5869488A (en) * 1996-05-01 1999-02-09 Schering Corporation Piperazino derivatives as neurokinin antagonists
US5968929A (en) * 1996-10-30 1999-10-19 Schering Corporation Piperazino derivatives as neurokinin antagonists
US6355643B1 (en) 1999-03-03 2002-03-12 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
US20100093935A1 (en) * 2008-10-15 2010-04-15 Nitto Denko Corporation Method of preparing polyglutamate conjugates
JP2013514443A (ja) * 2009-12-16 2013-04-25 日東電工株式会社 ポリグルタミン酸の制御された合成
ES2727815T3 (es) * 2012-04-14 2019-10-18 Intra Cellular Therapies Inc Tratamiento del TEPT y de trastornos del control de impulsos
BR112018015283B1 (pt) 2016-01-26 2023-09-26 Intra-Cellular Therapies, Inc Compostos orgânicos, composição farmacêutica compreendendo os ditos compostos e uso dos mesmos para o tratamento ou profilaxia de um distúrbio do sistema nervoso central
US10961245B2 (en) 2016-12-29 2021-03-30 Intra-Cellular Therapies, Inc. Substituted heterocycle fused gamma-carbolines for treatment of central nervous system disorders
WO2018126143A1 (en) 2016-12-29 2018-07-05 Intra-Cellular Therapies, Inc. Organic compounds

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3000892A (en) * 1959-11-16 1961-09-19 Paul A J Janssen 1-aroylalkyl-4-aroylpiperazines
DE1670431A1 (de) * 1966-03-04 1971-02-11 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung neuer Piperazin-Derivate
GB1143882A (es) * 1966-06-21
GB1186495A (en) * 1968-02-20 1970-04-02 Delalande Sa 0-[3-(4-Fluorobenzoyl) Proplyl]-4-Substituted Piperazines, their Acid Addition Salts and their method of preparation
FR2262521A1 (en) * 1973-08-08 1975-09-26 Delalande Sa 3-(3,4,5-Trimethoxyphenyl)piperazines - with coronary vasodilator, hypotensive, antiinflammatory, analgesic, and antiulcer activity
AR207031A1 (es) * 1974-03-06 1976-09-09 Kyorin Seiyaku Kk Procedimiento para preparacion de nuevos derivados de 1-(3-fenilpropil)-4-furoilpiperacina
JPS5143772A (en) * 1974-09-26 1976-04-14 Kyorin Seiyaku Kk 11 * 33 fuenirupuropiru * 44 furoirupiperajinjudotaino seizoho
JPS50131974A (es) * 1974-03-06 1975-10-18
JPS518283A (en) * 1974-07-09 1976-01-23 Kyorin Seiyaku Kk 11 * 33 fuenirupuropiru * 44 karubamoirupiperajinjudotaino seizoho
JPS5346988A (en) * 1976-10-07 1978-04-27 Kyorin Seiyaku Kk Piperadine derivative
NO154582C (no) * 1978-10-20 1986-11-05 Ferrosan Ab Analogifremgangsmaate for fremstilling av terapeutisk aktive difenyl-dibutylpiperazinkarboksamider.
WO1981003658A1 (en) * 1980-06-16 1981-12-24 Ferrosan Ab Diphenylbutyl-1-acylpiperazines
JPS58502056A (ja) * 1981-12-02 1983-12-01 アクチ−ボラグ　フエロサン １−ピペラジノカルボキシレ−ト、それらの製造方法およびそれらを含む医薬組成物

Also Published As

Publication number Publication date
HUT37415A (en) 1985-12-28
AU569537B2 (en) 1988-02-04
DK157864C (da) 1990-07-23
US4935419A (en) 1990-06-19
EP0136274A1 (en) 1985-04-03
EP0136274B1 (en) 1989-11-08
IE842050L (en) 1985-02-10
HU196977B (en) 1989-02-28
ES535027A0 (es) 1987-05-01
ES556989A0 (es) 1988-03-16
AU3211184A (en) 1985-03-12
ATE47850T1 (de) 1989-11-15
SE8304361D0 (sv) 1983-08-10
FI80449C (fi) 1990-06-11
DE3480395D1 (en) 1989-12-14
IE58065B1 (en) 1993-06-30
ES8705411A1 (es) 1987-05-01
DK157485A (da) 1985-04-09
JPH0723364B2 (ja) 1995-03-15
DK157485D0 (da) 1985-04-09
JPS60501956A (ja) 1985-11-14
IL72563A0 (en) 1984-11-30
DK157864B (da) 1990-02-26
IL72563A (en) 1988-10-31
FI851350L (fi) 1985-04-03
WO1985000811A1 (en) 1985-02-28
ES552001A0 (es) 1987-04-16
FI851350A0 (fi) 1985-04-03
ES8802039A1 (es) 1988-03-16
NZ209166A (en) 1987-07-31
CA1253148A (en) 1989-04-25
FI80449B (fi) 1990-02-28

Similar Documents

Publication Publication Date Title
ES8506001A1 (es) Un procedimiento para preparar compuestos de imidazol fusionados
ES8506677A1 (es) Un procedimiento para la preparacion de nuevos derivados de 8-cloro71,5-benzotiazepina.
ES8704917A1 (es) Procedimiento para prepararar derivados de 1-piperazinacarboximida.
ES8504749A1 (es) Procedimiento para preparar derivados de tiazol
SE7714184L (sv) Piperazinderivat
IL57577A0 (en) 1,2-dihydroquinolin-2-one derivatives,process for their preparation and pharmaceutical compositions containing the same
ATE74352T1 (de) Dekahydrochinolinderivate, verfahren zu ihrer herstellung, zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.
BG94282A (bg) 2,9-дизаместени-4н-пиридо/1,2,-а/пиримидин-4-они
ES482472A1 (es) Procedimiento para la preparacion de isoquinoleinas.
ATE59632T1 (de) Dihydrodibenzocycloheptylidenethylamin-derivate
ES8207180A1 (es) Procedimiento de fabricacion de derivados de tetrahidro-5,67,7a 4h-tieno (3,2-c) piridinona-2 .
ATE37533T1 (de) Derivate der 4-phenyl-4-oxo-buten-2-saeure, verfahren zu ihrer herstellung, medikamente und mischungen mit diesen derivaten.
EP0074130A3 (en) New imidazole compounds, process for the preparation thereof and pharmaceutical compositions containing them
ES8400743A1 (es) "procedimiento para la preparacion de compuestos de 1-fenilindazol-3-ona".
SE8903312L (sv) New 2-carbonyl substituted n,n'-di-(trimethoxybenzol)piperazines, process for preparing the same and therapeutical compounds containing them
FI833369A0 (fi) -aryl- -pyridylalkansyraderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutisk komposition
ES8702392A1 (es) Un procedimiento para preparar compuestos heterociclicos, en particular compuestos con un anillo de tiadiazinona
JPS5610173A (en) Analgesic
ES8600253A1 (es) Un procedimiento para preparar derivados de citosina
EG16489A (en) Process for the preparation of accridanone derivatives
ES484086A1 (es) Procedimiento para la preparacion de compuestos de isopropi-lamina
SE7905025L (sv) Tereftalsyramonoamidderivat, forfarande for framstellning derav och antiallergiskt medel
ZA838139B (en) Semicarbazides,process for preparing these,and pharmaceutical compositions thereof

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20060220